Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Annable

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Bulletin of the World Health Organization|January 1, 1972
The second international reference preparation of erythropoietin, human, urinary, for bioassayL Annable, P M Cotes, M V Mussett
Psychopharmacology|January 1, 1982
Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled studyG Chouinard, L Annable, R Fontaine, et al.
The Journal of Clinical Psychiatry|February 1, 1986
Clonazepam in the treatment of patients with recurrent panic attacksP Beaudry, R Fontaine, G Chouinard, et al.
The Journal of Clinical Psychiatry|June 1, 1982
Characteristics of chronically anxious patients who respond to EMG feedback trainingY J Lavellée, Y Lamontagne, L Annable, et al.
Advances in Experimental Medicine and Biology|March 18, 2000
A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoriaS Steinberg, L Annable, S N Young, et al.
Canadian Psychiatric Association Journal|August 1, 1975
Physiological and psychological effects of alpha and EMG feedback training with college drug users: a pilot studyY Lamontagne, I Hand, L Annable, et al.
Comprehensive Psychiatry|September 1, 1975
Postimperative negative variation (PINV) in ambulatory schizophrenic patientsG Chouinard, L Annable, B Dubrovsky, et al.
L'Union Medicale Du Canada|June 1, 1975
[Evaluation by multiple regression analysis of the clinical characteristics of a sample of adult-onset diabetics]J C Jéquier, M A Gagnon, L Annable
International Pharmacopsychiatry|January 1, 1977
A controlled study of a dopa decarboxylase inhibitor (benserazide) in the treatment of schizophrenic patientsG Chouinard, L Annable, M Serrano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepinesG Chouinard, A Labonte, R Fontaine, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Bulletin of the World Health Organization|January 1, 1972
The second international reference preparation of erythropoietin, human, urinary, for bioassayL Annable, P M Cotes, M V Mussett
Psychopharmacology|January 1, 1982
Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled studyG Chouinard, L Annable, R Fontaine, et al.
The Journal of Clinical Psychiatry|February 1, 1986
Clonazepam in the treatment of patients with recurrent panic attacksP Beaudry, R Fontaine, G Chouinard, et al.
The Journal of Clinical Psychiatry|June 1, 1982
Characteristics of chronically anxious patients who respond to EMG feedback trainingY J Lavellée, Y Lamontagne, L Annable, et al.
Advances in Experimental Medicine and Biology|March 18, 2000
A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoriaS Steinberg, L Annable, S N Young, et al.
Canadian Psychiatric Association Journal|August 1, 1975
Physiological and psychological effects of alpha and EMG feedback training with college drug users: a pilot studyY Lamontagne, I Hand, L Annable, et al.
Comprehensive Psychiatry|September 1, 1975
Postimperative negative variation (PINV) in ambulatory schizophrenic patientsG Chouinard, L Annable, B Dubrovsky, et al.
L'Union Medicale Du Canada|June 1, 1975
[Evaluation by multiple regression analysis of the clinical characteristics of a sample of adult-onset diabetics]J C Jéquier, M A Gagnon, L Annable
International Pharmacopsychiatry|January 1, 1977
A controlled study of a dopa decarboxylase inhibitor (benserazide) in the treatment of schizophrenic patientsG Chouinard, L Annable, M Serrano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepinesG Chouinard, A Labonte, R Fontaine, et al.
Pageof 10